Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature

Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature

Chondrosarcoma is a rare malignancy characterized by the production of cartilage matrix, displaying heterogeneous histopathology and clinical behavior. Due to lack of effective treatment for advanced disease, the clinical management of metastatic chondrosarcoma is exceptionally challenging. Chondros...

Full description

Bibliographic Details
Main Authors: Onoufrios Tsavaris, Panagiota Economopoulou, Ioannis Kotsantis, Lazaros Reppas, Chrysanthi Avgerinou, Nikolaos Spathas, Maria Prevezanou, Amanda Psyrri
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Oncology
Subjects:
pazopanib
metastatic chondrosarcoma
angiogenesis
vascular endothelial growth factor receptor
platelet-derived growth factor receptor
Online Access:http://journal.frontiersin.org/article/10.3389/fonc.2018.00045/full

Internet

http://journal.frontiersin.org/article/10.3389/fonc.2018.00045/full

Similar Items